BamSEC and AlphaSense Join Forces
Learn More

Nuo Therapeutics Inc.

OTC: AURX    
Share price (11/21/24): $1.09    
Market cap (11/21/24): $50.8 million

Articles of Incorporation Filter

EX-3.1
from 8-K 1 page Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation of Nuo Therapeutics, Inc
12/34/56
EX-3.2
from 8-A12G 30 pages Amended and Restated By-Laws of Nuo Therapeutics, Inc., a Delaware Corporation (The “Corporation”) (Adopted as of May 5, 2016) Amended and Restated By-Laws of Nuo Therapeutics, Inc
12/34/56
EX-3.3
from 8-K 7 pages Certificate of Designation of Series a Preferred Stock of Nuo Therapeutics, Inc. Pursuant to Section 151 of the General Corporation Law of the State of Delaware
12/34/56
EX-3.1
from 8-A12G 8 pages Second Amended and Restated Certificate of Incorporation of Nuo Therapeutics, Inc
12/34/56
EX-3.I6
from 10-Q 1 page State of Delaware Certificate of Amendment of the Certificate of Incorporation of Cytomedix, Inc
12/34/56
EX-3.1
from 8-K 1 page Cytomedix, Inc. Certificate of Amendment of Certificate of Incorporation
12/34/56
EX-3.1
from 8-K 1 page Cytomedix, Inc. Certificate of Amendment of Certificate of Incorporation
12/34/56
EX-3.1
from 8-K 1 page Cytomedix, Inc. Certificate of Amendment of Certificate of Incorporation
12/34/56
EX-3.2
from 10QSB 1 page State of Delaware Certificate of Amendment of Certificate of Incorporation the Corporation Organized and Existing Under and by Virtue of the General Corporation Law of the State of Delaware Does Hereby Certify: First: That at a Meeting of the Board of Directors of Cytomedix, Inc. Resolutions Were Duly Adopted Setting Forth a Proposed Amendment of the Amended and Restated Certificate of Incorporation of Said Corporation, Declaring Said Amendment to Be Advisable and Calling a Meeting of the Stockholders of Said Corporation for Consideration Thereof. the Resolution Setting Forth the Proposed Amendment Is as Follows: Resolved, That the First Sentence in Paragraph Four of the Amended and Restated Certificate of Incorporation Is Hereby Amended to Read as Follows: The Authorized Capital Stock of the Corporation Shall Consist of 80,000,000 Shares of Capital Stock, of Which 65,000,000 Shares Shall Be Common Stock, With a Par Value of $.0001 Per Share, and 15,000,000 Shares Shall Be Preferred Stock, With a Par Value of $.0001 Per Share. Second: That Thereafter, Pursuant to Resolution of Its Board of Directors, a Special Meeting of the Stockholders of Said Corporation Was Duly Called and Held Upon Notice in Accordance With Section 222 of the General Corporation Law of the State of Delaware at Which Meeting the Necessary Number of Shares as Required by Statute Were Voted in Favor of the Amendment. Third: That Said Amendment Was Duly Adopted in Accordance With the Provisions of Section 242 of the General Corporation Law of the State of Delaware. Fourth: That the Capital of Said Corporation Shall Not Be Reduced Under or by Reason of Said Amendment. in Witness Whereof, Said Corporation Has Caused This Certificate to Be Signed This 21st Day of October, 2004. By: /S/ William L. Allender William L. Allender Chief Financial Officer of Cytomedix, Inc
12/34/56
EX-3.2
from 10QSB ~10 pages Articles of Incorporation or Bylaws
12/34/56
EX-3.1
from 10QSB ~5 pages Articles of Incorporation or Bylaws
12/34/56